Literature DB >> 11083918

X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains.

K F Lau1, D M McLoughlin, C Standen, C C Miller.   

Abstract

X11 alpha and X11 beta are two neuronal adaptor proteins that interact with the Alzheimer's disease amyloid precursor protein (APP). X11 alpha and X11 beta stabilise APP and inhibit production of proteolytic APP fragments including the A beta peptide that is deposited in the brains of Alzheimer's disease patients. The mechanisms by which X11 alpha and X11 beta modulate APP processing are not clear but one possibility is that they influence the activity of the secretases that cleave APP to give rise to A beta. Presenilin-1 is required for gamma-secretase activity and here we demonstrate that both X11 alpha and X11 beta interact with presenilin-1. X11/presenilin-1 binding is via two X11 PDZ domains and sequences within the carboxy-terminus of presenilin-1. We also demonstrate that both X11 alpha and X11 beta mediate the formation of complexes between APP and presenilin-1. These results suggest that the X11 regulation of APP processing is controlled, at least in part, via their interactions with APP and presenilin-1. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083918     DOI: 10.1006/mcne.2000.0898

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  35 in total

Review 1.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 2.  Metabolism of presenilins.

Authors:  G Thinakaran
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission.

Authors:  Angela Ho; Wade Morishita; Robert E Hammer; Robert C Malenka; Thomas C Sudhof
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

Review 4.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Authors:  Gael Barthet; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Prog Neurobiol       Date:  2012-05-20       Impact factor: 11.685

5.  Cytoplasmic fragment of Alcadein α generated by regulated intramembrane proteolysis enhances amyloid β-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage.

Authors:  Norio Takei; Yuriko Sobu; Ayano Kimura; Satomi Urano; Yi Piao; Yoichi Araki; Hidenori Taru; Tohru Yamamoto; Saori Hata; Tadashi Nakaya; Toshiharu Suzuki
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

Review 6.  Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Authors:  Sic L Chan; Katsutoshi Furukawa; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Authors:  Dennis Dik-Long Chau; Kristen Wing-Yu Yung; William Wai-Lun Chan; Ying An; Yan Hao; Ho-Yin Edwin Chan; Jacky Chi-Ki Ngo; Kwok-Fai Lau
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

Review 8.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

9.  Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1.

Authors:  Yun Liu; Yun-Wu Zhang; Xin Wang; Han Zhang; Xiaoqing You; Francesca-Fang Liao; Huaxi Xu
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

10.  Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila.

Authors:  Garrett G Gross; R M Renny Feldman; Atish Ganguly; Jinhui Wang; Hong Yu; Ming Guo
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.